https://www.fda.gov/news-events/press-a ... e-covid-19
January 21, 2022
Today, the U.S. Food and Drug Administration took two actions to expand the use of the antiviral drug Veklury (remdesivir) to certain non-hospitalized adults and pediatric patients for the treatment of mild-to-moderate COVID-19 disease. This provides another treatment option to reduce the risk of hospitalization in high-risk patients. Previously, the use of Veklury was limited to patients requiring hospitalization.
https://www.forbes.com/sites/jvchamary/ ... 4e982c66c2
So now the FDA wants to start using Remdesivir in outpatient mild/moderate cases...
- harddriver
- Grand Poobah
- Posts: 5310
- Joined: Mon Jul 05, 2021 5:03 pm
- Has thanked: 588 times
- Been thanked: 1761 times
Who is online
Users browsing this forum: No registered users and 3 guests